These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25927535)

  • 1. The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria.
    Agalliu I; Adebiyi AO; Lounsbury DW; Popoola O; Jinadu K; Amodu O; Paul S; Adedimeji A; Asuzu C; Asuzu M; Ogunbiyi OJ; Rohan T; Shittu OB
    BMC Public Health; 2015 Apr; 15():425. PubMed ID: 25927535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
    Castro E; Mikropoulos C; Bancroft EK; Dadaev T; Goh C; Taylor N; Saunders E; Borley N; Keating D; Page EC; Saya S; Hazell S; Livni N; deSouza N; Neal D; Hamdy FC; Kumar P; Antoniou AC; Kote-Jarai Z; ; Eeles RA
    Oncologist; 2016 Jun; 21(6):716-22. PubMed ID: 27151655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
    Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
    Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased inflammatory potential of diet is associated with increased odds of prostate cancer in Argentinian men.
    Shivappa N; Niclis C; Coquet JB; Román MD; Hébert JR; Diaz MDP
    Cancer Causes Control; 2018 Sep; 29(9):803-813. PubMed ID: 30019102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer.
    Shoaibi A; Rao GA; Cai B; Rawl J; Haddock KS; Hébert JR
    Prostate; 2017 Feb; 77(2):173-184. PubMed ID: 27699819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.
    Drake BF; Keane TE; Mosley CM; Adams SA; Elder KT; Modayil MV; Ureda JR; Hebert JR
    J S C Med Assoc; 2006 Aug; 102(7):241-9. PubMed ID: 17319238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing dietary and other lifestyle factors among immigrant Nigerian men living in the US and indigenous men from Nigeria: potential implications for prostate cancer risk reduction.
    Kumar NB; Yu D; Akinremi TO; Odedina FT
    J Immigr Minor Health; 2009 Oct; 11(5):391-9. PubMed ID: 19225888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide association study of prostate cancer in Latinos.
    Du Z; Hopp H; Ingles SA; Huff C; Sheng X; Weaver B; Stern M; Hoffmann TJ; John EM; Van Den Eeden SK; Strom S; Leach RJ; Thompson IM; Witte JS; Conti DV; Haiman CA
    Int J Cancer; 2020 Apr; 146(7):1819-1826. PubMed ID: 31226226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of multiphase nonlinear mixed models to define and quantify long-term changes in serum prostate-specific antigen: data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Shoaibi A; Rao GA; Cai B; Rawl J; Hébert JR
    Ann Epidemiol; 2016 Jan; 26(1):36-42.e1-2. PubMed ID: 26611771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa.
    Tindall EA; Bornman MS; van Zyl S; Segone AM; Monare LR; Venter PA; Hayes VM
    BMC Urol; 2013 Dec; 13():74. PubMed ID: 24373635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction.
    Agalliu I; Wang Z; Wang T; Dunn A; Parikh H; Myers T; Burk RD; Amundadottir L
    PLoS One; 2013; 8(4):e60083. PubMed ID: 23573233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study.
    Brook MN; Ní Raghallaigh H; Govindasami K; Dadaev T; Rageevakumar R; Keating D; Hussain N; Osborne A; Lophatananon A; ; Muir KR; Kote-Jarai Z; Eeles RA
    Eur Urol; 2023 Mar; 83(3):257-266. PubMed ID: 36528478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a prostate cancer polygenic risk score.
    Black MH; Li S; LaDuca H; Lo MT; Chen J; Hoiness R; Gutierrez S; Tippin-Davis B; Lu HM; Gielzak M; Wiley K; Shi Z; Wei J; Zheng SL; Helfand BT; Isaacs W; Xu J
    Prostate; 2020 Nov; 80(15):1314-1321. PubMed ID: 33258481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
    Page EC; Bancroft EK; Brook MN; Assel M; Hassan Al Battat M; Thomas S; Taylor N; Chamberlain A; Pope J; Raghallaigh HN; Evans DG; Rothwell J; Maehle L; Grindedal EM; James P; Mascarenhas L; McKinley J; Side L; Thomas T; van Asperen C; Vasen H; Kiemeney LA; Ringelberg J; Jensen TD; Osther PJS; Helfand BT; Genova E; Oldenburg RA; Cybulski C; Wokolorczyk D; Ong KR; Huber C; Lam J; Taylor L; Salinas M; Feliubadaló L; Oosterwijk JC; van Zelst-Stams W; Cook J; Rosario DJ; Domchek S; Powers J; Buys S; O'Toole K; Ausems MGEM; Schmutzler RK; Rhiem K; Izatt L; Tripathi V; Teixeira MR; Cardoso M; Foulkes WD; Aprikian A; van Randeraad H; Davidson R; Longmuir M; Ruijs MWG; Helderman van den Enden ATJM; Adank M; Williams R; Andrews L; Murphy DG; Halliday D; Walker L; Liljegren A; Carlsson S; Azzabi A; Jobson I; Morton C; Shackleton K; Snape K; Hanson H; Harris M; Tischkowitz M; Taylor A; Kirk J; Susman R; Chen-Shtoyerman R; Spigelman A; Pachter N; Ahmed M; Ramon Y Cajal T; Zgajnar J; Brewer C; Gadea N; Brady AF; van Os T; Gallagher D; Johannsson O; Donaldson A; Barwell J; Nicolai N; Friedman E; Obeid E; Greenhalgh L; Murthy V; Copakova L; Saya S; McGrath J; Cooke P; Rønlund K; Richardson K; Henderson A; Teo SH; Arun B; Kast K; Dias A; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Eccles DM; Tricker K; Eyfjord J; Falconer A; Foster C; Gronberg H; Hamdy FC; Stefansdottir V; Khoo V; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra A; Moynihan C; Rennert G; Suri M; Wilson P; Dudderidge T; ; Offman J; Kote-Jarai Z; Vickers A; Lilja H; Eeles RA
    Eur Urol; 2019 Dec; 76(6):831-842. PubMed ID: 31537406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study.
    Spain P; Carpenter WR; Talcott JA; Clark JA; Do YK; Hamilton RJ; Galanko JA; Jackman A; Godley PA
    Cancer; 2008 Oct; 113(8):2180-7. PubMed ID: 18798229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of elevated serum prostate-specific antigen in rural Nigeria.
    Ukoli F; Osime U; Akereyeni F; Okunzuwa O; Kittles R; Adams-Campbell L
    Int J Urol; 2003 Jun; 10(6):315-22. PubMed ID: 12757603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy.
    Grizzle WE; Kittles RA; Rais-Bahrami S; Shah E; Adams GW; DeGuenther MS; Kolettis PN; Nix JW; Bryant JE; Chinsky R; Kearns JE; Dehimer K; Terrin N; Chang H; Gaston SM
    Cancer Med; 2019 Nov; 8(16):6915-6922. PubMed ID: 31568648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics.
    Agalliu I; Williams S; Adler B; Androga L; Siev M; Lin J; Xue X; Huang G; Strickler HD; Ghavamian R
    Cancer Causes Control; 2015 Jun; 26(6):821-30. PubMed ID: 25771797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Potential Genes for Benign Prostatic Hyperplasia and Prostate Cancer Susceptibility in Four X-chromosome Regions with High Frequency of Microvariant Alleles.
    Albujja MH; Messaudi SA; Vasudevan R; Al Ghamdi S; Chong PP; Ghani KA; Ranneh Y; Alaidarous M; Ismail P
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2271-2280. PubMed ID: 32856855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of prostatic carcinoma among blacks: a comparison between a low-incidence area, Ibadan, Nigeria, and a high-incidence area, Washington, DC.
    Jackson MA; Kovi J; Heshmat MY; Ogunmuyiwa TA; Jones GW; Williams AO; Christian EC; Nkposong EO; Rao MS; Jackson AG; Ahluwalia BS
    Prostate; 1980; 1(2):185-205. PubMed ID: 15619919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.